Displaying 61 - 72 of 490
Metabolism, Alcohol & Toxicity

Sanofi: Reducing the burden of liver disease - new evidence revealed (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Metabolic Comorbidities Unmasked -  Redefining MASLD/MASH Impact

Webcasts
View
Metabolism, Alcohol & Toxicity

Shedding light on genomic, metabolic, and phenotypic effects of essential phospholipids on HepaRG

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Chair’s Welcome and Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Immune-Mediated and Cholestatic Diseases

“Continuing the Conversation” Cholesastic Liver Disease, Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum: Meet the Experts in Cholestatic Liver Disease (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Chair’s Welcome and Introduction

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Potential for IBAT Inhitors in PSC: Will the Paediatric Experience Translate to Adults?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IBAT Inhibitor Mechanism of Action and Experience in Paediactrics

Webcasts
View
Displaying 61 - 72 of 490